The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Plasma and urine free glycosaminoglycans as monitoring and predictive biomarkers in metastatic renal cell carcinoma: A prospective observational study.
 
Francesco Gatto
Employment - Elypta
Leadership - Elypta
Stock and Other Ownership Interests - Elypta
Travel, Accommodations, Expenses - Elypta
 
Sinisa Bratulic
Travel, Accommodations, Expenses - Elypta
 
Eric Jonasch
Consulting or Advisory Role - aravive; Calithera Biosciences; Eisai; Exelixis; Merck; NiKang Therapeutics; Novartis; Pfizer
Research Funding - Aravive; Novartis; Peloton Therapeutics
Travel, Accommodations, Expenses - Pfizer
 
Angelo Limeta
Travel, Accommodations, Expenses - Elypta
 
Francesca Maccari
No Relationships to Disclose
 
Fabio Galeotti
No Relationships to Disclose
 
Nicola Volpi
No Relationships to Disclose
 
Sven Lundstam
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; MSD
 
Jens Nielsen
Stock and Other Ownership Interests - Elypta
 
Ulrika Stierner
Expert Testimony - Bristol-Myers Squibb; Ipsen; MSD; Pfizer